Update: COVID-19 Pandemic–Associated Changes in Emergency Department Visits — United States, December 2020–January 2021

During March 29–April 25, 2020, emergency department (ED) visits in the United States declined by 42% after the declaration of a national emergency for COVID-19 on March 13, 2020. Among children aged ≤10 years, ED visits declined by 72% compared with prepandemic levels (1). To assess the continued impact of the COVID-19 pandemic on EDs, CDC examined trends in visits since December 30, 2018, and compared the numbers and types of ED visits by patient demographic and geographic factors during a COVID-19 pandemic period (December 20, 2020–January 16, 2021) with a prepandemic period 1 year earlier (December 15, 2019–January 11, 2020). After an initial decline during March–April 2020 (1), ED visits increased through July 2020, but at levels below those during the previous year, until December 2020–January 2021 when visits again fell to 25% of prepandemic levels. During this time, among patients aged 0–4, 5–11, 12–17, and ≥18 years, ED visits were lower by 66%, 63%, 38%, and 17%, respectively, compared with ED visits for each age group during the same period before the pandemic. Differences were also observed by region and reasons for ED visits during December 2020–January 2021; more visits during this period were for infectious diseases or mental and behavioral health–related concerns and fewer visits were for gastrointestinal and upper-respiratory–related illnesses compared with ED visits during December 2019–January 2020. Although the numbers of ED visits associated with socioeconomic factors and mental or behavioral health conditions are low, the increased visits by both adults and children for these concerns suggest that health care providers should maintain heightened vigilance in screening for factors that might warrant further treatment, guidance, or intervention during the COVID-19 pandemic.

Data were obtained from the National Syndromic Surveillance Program (NSSP),* a collaborative system developed and maintained by CDC, state and local health departments, and academic and private sector health partners. NSSP collects electronic health data in near real-time, including ED visits from a subset of hospitals in 49 states (all but Hawaii) and the District of Columbia. This study analyzed information collected from approximately 71% of nonfederal facilities, nationwide, using data for all ED visits from participating hospitals in the 46 states that reported ED visits consistently during the prepandemic (December 15, 2019–January 11, 2020) and pandemic (December 20, 2020–January 16, 2021) periods assessed. All hospitals in Hawaii, Ohio, South Dakota, and Wyoming, and hospitals in other states that started or stopped reporting during 2019–2021 were excluded. Patient diagnoses were analyzed using a subset of records that included at least one specific, billable International Classification of Diseases, Tenth Revision, Clinical Modification (ICD-10-CM) code. Facilities that did not report diagnostic codes consistently or reported incomplete codes during 2019–2021 were excluded. ED visits were categorized using the Clinical Classifications Software Refined tool from the Healthcare Cost and Utilization Project, which combines ICD-10-CM codes into clinically meaningful groups (2).

This analysis was limited to the top 200 diagnostic categories (pediatric = 455 total diagnostic categories; adult = 497 total diagnostic categories) for each patient-level category evaluated during the assessed periods. The 10 categories with the highest and lowest significant (p<0.05) prevalence ratios (PRs)^† were identified. Trends in ED visits during December 30, 2018–January 16, 2021 were examined; overall analysis of trends focused on the prepandemic period during December 15, 2019–January 11, 2020 and the pandemic period during December 20, 2020–January 16, 2021, with comparisons by patient sex, age, U.S. Department of Health and Human Services (HHS) region,^§ and reason for the visit. Estimates of weekly change^¶ and PRs were calculated to assess differences in numbers of ED visits between the two periods. All analyses were conducted using R software (version 4.0.; The R Foundation) This activity was reviewed by CDC and was conducted consistent with applicable federal law and CDC policy.**

After decreasing by 42% during March–April 2020 (1), overall U.S. ED visits increased through July 2020 then stabilized in August 2020 at levels 15% below those during the same prepandemic period. During December 2020–January 2021, numbers of visits declined again to a level 25% lower than those during the previous year (December 2019–January 2020) (Figure), including a 23% decline in visits by males and a 27% decline in visits by females. During December 2020–January 2021, the numbers of ED visits in all age groups were lower than were those during the prepandemic period. The largest observed decline in visits was among children, especially those aged 0–4 years (66%) and 5–11 years (63%) (Supplementary Figure 1, https://stacks.cdc.gov/view/cdc/104808). ED visits by adults aged ≥18 years were 17% lower than ED visits during the prepandemic period (Figure). During December 2020–January 2021, ED visits varied by HHS region, ranging from an overall 29% decrease in the upper Midwest to a 21% decrease in the Northeast. ED visits by adults and pediatric patients declined in all regions (Supplementary Figure 2, https://stacks.cdc.gov/view/cdc/104808), ranging from a 23% decrease in the West (Region 9) to a 14% decrease in the Northeast (Region 3) among adults, and from 65% in the Northeast (Region 2) to 53% in the Midwest (Region 7) among children.

During December 2020–January 2021, the proportion of ED visits for infectious disease–related concerns (i.e., exposure, encounters, screening, or contact with infectious disease) was higher than that during the same period before the pandemic for adults (PR = 5.86) and children (PR = 9.22), as were the proportion of visits related to socioeconomic and psychosocial (mental and behavioral health–related concerns) factors (adults PR = 1.37; children PR = 2.56). Among adults, the proportion of ED visits during this period was also higher than that during the prepandemic period for menopausal disorders (PR = 1.89); respiratory failure, insufficiency, and arrest (PR = 1.62); acute pulmonary embolism (PR = 1.59); cardiac arrest and ventricular fibrillation (PR = 1.45); malaise and fatigue (PR = 1.34); acute and unspecified renal failure (PR = 1.33); and symptoms of mental and substance-use conditions (PR = 1.28) (Table 1). Among children, the proportion of ED visits during this period was higher compared with the prepandemic period for calculus of the urinary tract (PR = 2.70); open wounds to limbs, subsequent encounter (PR = 2.67); suicidal ideation, attempt, and intentional self-harm (PR = 2.64); sexually transmitted infections (HIV and viral hepatitis) (PR = 2.57); schizophrenia spectrum and other psychotic disorders (PR = 2.55); lifestyle and life management factors (e.g., tobacco use, lack of physical exercise, high-risk sexual behavior, sleep deprivation or insomnia, or stress or burnout) (PR = 2.55); feeding and eating disorders (PR = 2.52); and open wounds of the head and neck, subsequent encounter (PR = 2.51) (Table 2). Decreases in the proportion of ED visits related to gastrointestinal and upper respiratory–related factors were identified in both adults and children, with the largest declines among children for influenza (PR = 0.01), acute bronchitis (PR = 0.17), pneumonia except that caused by tuberculosis (PR = 0.30), otitis media (0.36), and sinusitis (PR = 0.42).

Acknowledgments

Tegan Boehmer; Lesliann Helmus; Adi Gundlapalli; Paula Yoon.

Corresponding author: Jennifer Adjemian, [email protected].

¹CDC COVID-19 Response Team; ²ICF International Inc., Atlanta, Georgia.

References

1. Hartnett KP, Kite-Powell A, DeVies J, et al. Impact of the COVID-19 pandemic on emergency department visits—United States, January 1, 2019–May 30, 2020. MMWR Morb Mortal Wkly Rep 2020;69:699–704. https://doi.org/10.15585/mmwr.mm6923e1 PMID:32525856
2. Agency for Healthcare Research and Quality. Healthcare Cost and Utilization Project. Clinical classifications software refined. Rockville, MD: US Department of Health and Human Services, Agency for Healthcare Research and Quality, 2020. www.hcup-us.ahrq.gov/toolssoftware/ccsr/ccs_refined.jsp
3. Weisz D, Gusmano MK, Wong G, Trombley J. Emergency department use: a reflection of poor primary care access? Am J Manag Care 2015;21:e152–60. PMID:25880489
4. Taquet M, Luciano S, Geddes JR, Harrison PJ. Bidirectional associations between COVID-19 and psychiatric disorder: retrospective cohort studies of 62 354 COVID-19 cases in the USA. Lancet Psychiatry 2021;8:130–40. https://doi.org/10.1016/S2215-0366(20)30462-4 PMID:33181098
5. Pan KY, Kok AAL, Eikelenboom M, et al. The mental health impact of the COVID-19 pandemic on people with and without depressive, anxiety, or obsessive-compulsive disorders: a longitudinal study of three Dutch case-control cohorts. Lancet Psychiatry 2021;8:121–9. https://doi.org/10.1016/S2215-0366(20)30491-0 PMID:33306975
6. CDC. ICD-10-CM official coding and reporting guidelines April 1, 2020 through September 30, 2020. Atlanta, GA: US Department of Health and Human Services, CDC; 2020. https://www.cdc.gov/nchs/data/icd/COVID-19-guidelines-final.pdf
7. CDC. COVID-19: framework for healthcare systems providing non-COVID-19 clinical care during the COVID-19 pandemic. Atlanta, GA: US Department of Health and Human Services, CDC; 2020. Accessed January 11, 2020. https://www.cdc.gov/coronavirus/2019-ncov/hcp/framework-non-COVID-care.html

FIGURE. Weekly number of total,* adult,^† and pediatric^§ emergency department (ED) visits and COVID-19–like illness visits — National Syndromic Surveillance Program, United States,^¶ December 30, 2018–January 16, 2021

* Total, adult, and pediatric visits include visits for COVID-19–like illness.
^† Patients aged ≥18 years.
^§ Patients aged <18 years.
^¶ Forty-six states and the District of Columbia. All facilities in Hawaii, Ohio, South Dakota, and Wyoming, and facilities in other states that started or stopped reporting to the National Syndromic Surveillance Program during 2019–2021 were excluded.

Abbreviation: CI = confidence interval.
* Prepandemic period analyzed was December 15, 2019–January 11, 2020; pandemic period analyzed was December 20, 2020–January 16, 2021.
^† The weekly change in ED visits during the pandemic and comparison prepandemic periods was calculated as the difference in total counts between the two periods, divided by 4 weeks. Absolute change in mean number of ED visits for each diagnostic category is presented as a data label within parentheses. In the pandemic period, the average weekly visits across facilities for adults was 403 (range = 0.25–5,906) and in the comparison period, the average weekly visits across facilities for adults was 493 (range = 0.25–11,756).
^§ Ratio calculated as the proportion of all ED visits in each diagnostic category during the pandemic period, divided by the proportion of all ED visits in that category during the comparison period. Ratios >1 indicate a higher proportion of visits in that category during the pandemic period than during the comparison period; ratios <1 indicate a lower proportion during the pandemic period than during the comparison period.
^¶ ED visits were categorized using the Clinical Classifications Software Refined tool from the Healthcare Cost and Utilization Project, which combines International Classification of Diseases, Tenth Revision, Clinical Modification codes into clinically meaningful groups. https://www.hcup-us.ahrq.gov/toolssoftware/ccsr/dxccsr.jsp
** The analysis was limited to the top 200 diagnostic categories for each patient-level category (pediatric = 455 total diagnostic categories; adult = 497 total diagnostic categories) evaluated during the assessed period. The 10 categories with the highest and lowest significant (p<0.05) PRs were identified.
^†† Only facilities consistently reporting informative discharge diagnoses in the two periods (i.e., not null and without terms like “unknown”) were included in the analysis. Forty-six states and the District of Columbia are included. All facilities in Hawaii, Ohio, South Dakota, and Wyoming, and facilities in other states that started or stopped reporting to the NSSP during 2019–2021 were excluded.

Abbreviation: CI = confidence interval.
* Prepandemic period analyzed was December 15, 2019–January 11, 2020; pandemic period analyzed was December 20, 2020–January 16, 2021.
^† The weekly change in ED visits during the pandemic and comparison prepandemic periods was calculated as the difference in total counts between the two periods, divided by 4 weeks. Absolute change in mean number of ED visits for each category in the figures is presented as a data label within parentheses. In the pandemic period, the average weekly visits across facilities for pediatrics was 50 (range = 0.25–1,316) and in the comparison period the average weekly visits across facilities for pediatrics was 122 (range = 0.25–2,565).
^§ Ratio calculated as the proportion of all ED visits in each diagnostic category during the pandemic period, divided by the proportion of all ED visits in that category during the comparison period. Ratios >1 indicate a higher proportion of visits in that category during the pandemic period than during the comparison period; ratios <1 indicate a lower proportion during the pandemic period than during the comparison period.
^¶ ED visits were categorized using the Clinical Classifications Software Refined tool from the Healthcare Cost and Utilization Project, which combines International Classification of Diseases, Tenth Revision, Clinical Modification codes into clinically meaningful groups. https://www.hcup-us.ahrq.gov/toolssoftware/ccsr/dxccsr.jsp
** The analysis was limited to the top 200 diagnostic categories for each patient-level category (pediatric = 455 total diagnostic categories; adult = 497 total diagnostic categories) evaluated during the assessed period. The 10 categories with the highest and lowest significant (p<0.05) PRs were identified.
^†† Only facilities consistently reporting informative discharge diagnoses in the two periods (i.e., not null and without terms like “unknown”) were included in the analysis. Forty-six states and the District of Columbia are included. All facilities in Hawaii, Ohio, South Dakota, and Wyoming, and facilities in other states that started or stopped reporting to the NSSP during 2019–2021 were excluded.